慢性鼻-鼻窦炎的内在型:从基础到临床

doi:10.6040/j.issn.1673-3770.1.2017.054

摘要/Abstract

摘要： 慢性鼻-鼻窦炎(CRS)是多因素作用下鼻及鼻窦黏膜的慢性持续性炎症,具有高度异质性,病理机制非常复杂,临床表现型相同,其内在型和预后可能不同。CRS内在型是对不同个体CRS发病内在本质的研究,是从细胞和分子生物学角度探索疾病的发病本质,随着CRS内在型研究的不断深入,期望能找到某些特定的分子标志物,以这些分子标志物为靶标实现个体化的精准治疗。

关键词: 精准治疗, 慢性, 分子生物学, 鼻-鼻窦炎

Abstract: Chronic rhinosinusitis(CRS)is a complex disease that involves multiple factors and is characterized by chronic persistent inflammation of the nasal and sinus mucosa. Owing to the high heterogeneity and complicated pathological mechanism, polyps of different endotypes may exhibit the same phenotype. The present research on the endotype of chronic rhinosinusitis focuses on the cellular and molecular biology aspects of the disease onset. We expect to identify specific molecular markers, which can be used as target molecules for accurate individualized treatment.

Key words: Accurate treatment, Molecular biology, Rhinosinusitis, chronic

中图分类号:

R765.4

张桂敏,林鹏. 慢性鼻-鼻窦炎的内在型:从基础到临床[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 14-17.

ZHANG Guimin, LIN Peng. Endotype of chronic rhinosinusitis: from basic to clinical research[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 14-17.

参考文献

[1] 周兵, 韩德民.鼻内镜外科基本技术的再认识与发展[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(6):441-443.
[2] Bachert C, Holtappels G. Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options[J]. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2015, 14:Doc09. DOI:10.3205/cto000124.
[3] Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps[J]. J Allergy Clin Immunol, 2006, 118(5):1133-1141.
[4] Gevaert P, Van BN, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis[J]. J Allergy Clin Immunol, 2011, 128(5):989-995.
[5] Gevaert P, Calus L, Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma[J]. J Allergy Clin Immunol, 2013, 131(1):110-116.
[6] Lane AP, Truongtran QA, Schleimer RP.Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps[J]. Am J Rhinol, 2006, 20(2):138-144.
[7] Adappa ND, Zhang Z, Palmer JN, et al. The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery[J]. Int Forum Allergy Rhinol, 2014, 4(1):3-7.
[8] Lee RJ, Cohen NA.The emerging role of the bitter taste receptor T2R38 in upper respiratory infection and chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2013, 27(4):283-286.
[9] Nagarkar DR, Poposki JA, Tan BK, et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2013, 132(3):593-600.
[10] Baba S, Kondo K, Kanaya K, et al. Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps[J]. Laryngoscope, 2014, 124(4):E115-122.
[11] Lam M, Hull L, Mclachlan R, et al. Clinical severity and epithelial endotypes in chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2013, 3(2):121-128.
[12] Lam M, Hull L, Imrie A, et al. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2015, 29(3):175-178.
[13] Yao T, Kojima Y, Koyanagi A, et al. Eotaxin-1, -2, and-3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients[J]. Laryngoscope, 2009, 119(6):1053-1059.
[14] Divekar R, Kita H.Recent advances in epithelium-derived cytokines(IL-33, IL-25, and thymic stromal lymphopoietin)and allergic inflammation[J]. Curr Opin Allergy Clin Immunol, 2015, 15(1):98-103.
[15] Lam M, Hull L, Mclachlan R, et al. Clinical severity and epithelial endotypes in chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2013, 3(2):121-128.
[16] Shin HW, Kim DK, Park MH, et al. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2015, 135(6):1476-1485.
[17] Kato A, Favoreto S, Avila PC, et al. TLR3-and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells[J]. J Immunol, 2007, 179(2):1080-1087.
[18] Lee HC, Ziegler SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB[J]. Proc Natl Acad Sci U S A, 2007, 104(3):914-919.
[19] Boita M, Garzaro M, Raimondo L, et al. Eosinophilic inflammation of chronic rhinosinusitis with nasal polyps is related to OX40 ligand expression[J]. Innate Immun, 2015, 21(2):167-174.
[20] Liu T, Li TL, Zhao F, et al. Role of thymic stromal lymphopoietin in the pathogenesis of nasal polyposis[J]. Am J Med Sci, 2011, 341(1):40-47.
[21] Mjösberg JM, Trifari S, Crellin NK, et al. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161[J]. Nat Immunol, 2011, 12(11):1055-1062.
[22] Robinette ML, Colonna M.Immune modules shared by innate lymphoid cells and T cells[J]. J Allergy Clin Immunol, 2016, 138(5):1243-1251.
[23] Morita H, Moro K, Koyasu S. Innate lymphoid cells in allergic and nonallergic inflammation[J]. J Allergy Clin Immunol, 2016, 138(5):1253-1264.
[24] Bal SM, Bernink JH, Nagasawa M, et al. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs[J]. Nat Immunol, 2016, 17(6):636-645.
[25] Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators[J]. Allergy, 2006, 61(11):1280-1289.
[26] Zhang N, Van ZT, Pereznovo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease[J]. J Allergy Clin Immunol, 2008, 122(5):961-968.
[27] Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania[J]. J Allergy Clin Immunol, 2016, 138(5):1344-1353.
[28] Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers[J]. J Allergy Clin Immunol, 2016, 137(5):1449-1456.
[29] Kim JW, Hong SL, Kim Yk, et al. Histological and immunological features of non-eosinophilic nasal polyps[J]. Otolaryngol Head Neck Surg, 2007, 137(6):925-930.
[30] Ba L, Zhang N, Meng J, et al. The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps[J]. Allergy, 2011, 66(10):1296-1303.
[31] Orlandi RR, Kingdom TT, Hwang PH. International consensus statement on allergy and rhinology: rhinosinusitis executive summary[J]. Int Forum Allergy Rhinol, 2016. DOI: 10.1002/alr.21694.
[32] Sommer DD, Rotenberg BW, Sowerby LJ, et al. A novel treatment adjunct for aspirin exacerbated respiratory disease:the low-salicylate diet:a multicenter randomized control crossover trial[J]. Int Forum Allergy Rhinol, 2016, 6(4):385-391.
[33] Cingi C, Muluk NB, Ipci K, et al. Antileukotrienes in upper airway inflammatory diseases[J]. Curr Allergy Asthma Rep, 2015, 15(11):64.
[34] Laidlaw TM, Kidder MS, Bhattacharyya N, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes[J]. Blood, 2012, 119(16):3790-3798.

相关文章 15

[1]	吴喜福, 孔维封, 王玮豪, 徐惠清, 戚敏, 杨钦泰. QoR-15在加速康复外科改善慢性鼻-鼻窦炎伴鼻息肉围手术期生活质量评估中的应用[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 5-8.
[2]	乔叔芬,杨飞轮,王臻妮,李学忠. YKL-40与慢性鼻-鼻窦炎组织重构的相关性探讨[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 95-99.
[3]	陈望兴,赵雪,刘岩,刘悦,金春顺. 鼻中隔偏曲及慢性鼻窦炎鼻息肉患者的精神心理状态调查[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 24-27.
[4]	黄凯丰. 糖皮质激素短疗程雾化吸入对嗜酸粒细胞性鼻窦炎伴鼻息肉患者鼻部症状及肾上腺皮质功能的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 28-31.
[5]	陈鸣,俞雪飞. 浅谈伴有变应性鼻炎的慢性鼻窦炎的治疗[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 18-22.
[6]	娄鸿飞,王成硕. 慢性鼻窦炎分型研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 10-13.
[7]	李华斌, 赖玉婷. 慢性鼻-鼻窦炎的发病机制及诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 4-9.
[8]	张炜,曾昱菡,余先崧. 慢性鼻窦炎手术前后ECP、EGF、IL-6的水平变化及临床意义[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 63-67.
[9]	李莹. 慢性鼻窦炎的辨证论治[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 27-30.
[10]	张劼,龚齐. 不同分型慢性鼻-鼻窦炎患者外周血嗜酸性粒细胞与中性粒细胞百分比及变态反应临床差异性分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 54-57.
[11]	甘彬,张永举,许安廷. BRF2在慢性鼻-鼻窦炎伴鼻息肉发病过程中的作用研究[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 47-53.
[12]	郑雅霓, 刘鹤, 马亮, 张明生, 孙中武. 布地奈德联合生理盐水鼻腔冲洗对慢性鼻-鼻窦炎的疗效及对鼻腔分泌物IL-6、IL-8、TNF-α的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 58-62.
[13]	曲中源,曲汝鹏,王爱平,冷辉,石磊,孙海波. 孙海波教授治疗慢性鼻-鼻窦炎经验[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 105-107.
[14]	龚齐,张劼,赵屏屏. 鼻腔扩容术对慢性鼻-鼻窦炎伴睡眠呼吸暂停[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 52-55.
[15]	林兴,林宗通,沈翎. 鼻窦球囊扩张治疗儿童慢性鼻窦炎的系统评价及Meta分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 79-86.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed